Phase III trial of docetaxel (D), estramustine (E), and prednisone versus docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer (HRPC) No significant financial ...
(A) The infection of Ad-Shh in MSCs (fluorescence microscope, × 100). (B) Validation of the expression of Shh by Ad-Shh in MSCs (Western blot). (C, D) The effects of Shh on BMP9-induced ALP activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results